Differential Regulation of Rat and Human CYP7A1 by the Nuclear Oxysterol Receptor Liver X Receptor-α

B Goodwin, MA Watson, H Kim, J Miao… - Molecular …, 2003 - academic.oup.com
B Goodwin, MA Watson, H Kim, J Miao, JK Kemper, SA Kliewer
Molecular endocrinology, 2003academic.oup.com
In rodent liver, transcription of the gene encoding cholesterol 7α-hydroxylase (CYP7A1),
which catalyzes the rate-limiting step in the classic bile acid synthetic pathway, is stimulated
by the liver X receptor α (LXRα), a nuclear receptor for oxysterol metabolites of cholesterol.
This feed-forward regulatory loop provides a mechanism for the elimination of excess
cholesterol from the body. In this report, we demonstrate that in primary cultures of human
hepatocytes, activation of LXRα has the opposite effect, repressing CYP7A1 expression …
Abstract
In rodent liver, transcription of the gene encoding cholesterol 7α-hydroxylase (CYP7A1), which catalyzes the rate-limiting step in the classic bile acid synthetic pathway, is stimulated by the liver X receptor α (LXRα), a nuclear receptor for oxysterol metabolites of cholesterol. This feed-forward regulatory loop provides a mechanism for the elimination of excess cholesterol from the body. In this report, we demonstrate that in primary cultures of human hepatocytes, activation of LXRα has the opposite effect, repressing CYP7A1 expression. This repression is mediated, at least in part, through induction of the orphan nuclear receptor, short heterodimer partner (SHP), which is also induced by bile acids. We demonstrate that SHP is regulated directly by LXRα through a DNA response element that overlaps with the previously characterized bile acid response element. Our data reveal a fundamental difference in the regulation of CYP7A1 in rodent and human hepatocytes and provide evidence that different species employ distinct molecular strategies to regulate cholesterol homeostasis.
Oxford University Press